Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2008 by Genexine, Inc..
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Seoul National University Hospital
Information provided by:
Genexine, Inc.
ClinicalTrials.gov Identifier:
NCT00517569
First received: August 16, 2007
Last updated: May 8, 2008
Last verified: May 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2009
  Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)